North & South - - Four Corners -

For a small New Zealand skin­care com­pany, re­search and de­vel­op­ment has re­ally paid off.

First, Snow­berry founder So­raya Hen­desi had Auck­land Univer­sity School of Phar­macy sci­en­tists test her cop­per pep­tide serum to see if the “mes­sen­ger” role of pep­tides in the pro­duc­tion of col­la­gen could im­prove age­ing skin. Then the Auck­land-based com­pany sub­mit­ted its “Cu-pep” cream to a dou­ble-blind, in­de­pen­dent clin­i­cal trial in Ger­many.

Hen­desi says the re­search was a gam­ble, but her faith in the prod­uct was re­warded: the serum out­per­formed the placebo by more than 55% and a suc­cess­ful, niac­in­based Amer­i­can skin prod­uct called Strivectin by more than 30%.

The re­sults earned Snow­berry an in­vi­ta­tion to present its find­ings at the World Congress of Der­ma­tol­ogy – a rare hon­our for an over-the­counter skin­care range. It also put it on the radar of a multi­na­tional man­u­fac­turer, which has picked up the 12-year-old com­pany and has plans to take it global.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.